Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib treatment is used for teenagers with alopecia areata.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Tadalafil and Finasteride may help treat aggressive melanoma.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Upadacitinib may cause hair loss.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

JAK inhibitors show promise in treating difficult skin diseases.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Krill oil may help reduce prostate enlargement and growth.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

CS12192 effectively treats alopecia areata with better safety than current options.